Ricoh USA, Inc. has introduced a groundbreaking lineup of intelligent color A3 multifunction printers (MFPs) featuring an ...

Rheumatologists and dermatologists highlight Saphnelo, Sotyktu, and litifilimab as leading candidates to address unmet needs in CLE patients, particularly those with systemic involvementEXTON, PA, ...

The live webcast can be accessed by clicking here . To ask questions on the conference call, participants need to register in advance by clicking here . Registered telephone participants will receive ...

ProRx Pharma has announced the release of four injectables as part of its health and wellness product line, coupled with the ...

Ricoh USA, Inc. today announced a new lineup of intelligent color A3 multifunction printers (MFPs) with a revolutionary ...

JLL has arranged the $34.3 million sale of Exton Square, a 990,000-square-foot super-regional shopping center located on the western outskirts of Philadelphia. The center was originally built on 75 ...

The new product line includes Sermorelin, NAD+, Glutathione and MIC/B6/B12 to help meet demand as physicians and patients focus more on preventative health measures ...

ATMOS Inc. is proud to announce that its ATMOS C 051 Cardiothoracic Digital Drain and Observation System has received FDA clearance. EXTON, PA / ACCESS Newswire / April 2, 2025 / Designed to support ...

Macy’s hasn’t been hit that hard yet, but the retailer announced in January that it was planning to shutter 150 stores that it found to be “underproductive” by 2026, and USA Today reported this week ...

Skies will start widely clear this evening. Overnight, areas of low cloud will develop from the east, with local mist also possible in places. A chilly night. Wednesday A partly cloudy start ...

Omega Flex, Inc. (the “Company”) (NASDAQ: OFLX) today announced that the Board of Directors declared a regular quarterly dividend of $0.34 per share payable on April 22, 2025, to shareholders of ...

In late 2024, Bristol Myers Squibb announced positive topline results from its pivotal Phase 3 trials, POETYK PsA-1 and PsA-2, evaluating Sotyktu ...